These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7788992)

  • 1. An approach to cerebral vasodilatory capacity in unilateral and bilateral cerebrovascular diseases using radiolabeled human serum albumin.
    Inoue Y; Momose T; Machida K; Honda N; Mamiya T; Takahashi T; Tsutsumi K
    Clin Nucl Med; 1995 Apr; 20(4):340-5. PubMed ID: 7788992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease.
    Inoue Y; Momose T; Machida K; Honda N; Tsutsumi K
    J Nucl Med; 1993 Nov; 34(11):1984-6. PubMed ID: 8229245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPECT measurements of cerebral blood volume before and after acetazolamide in occlusive cerebrovascular diseases.
    Inoue Y; Momose T; Machida K; Honda N; Nishikawa J; Sasaki Y
    Radiat Med; 1994; 12(5):225-9. PubMed ID: 7863027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method for monitoring the cerebrovascular response to acetazolamide using 99mTc-DTPA-HSA.
    Inoue Y; Momose T; Machida K; Honda N; Mamiya T; Takahashi T; Kamano T; Muramatsu M; Kashimada A
    Radiat Med; 1992; 10(2):45-7. PubMed ID: 1626056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. A comparison with acetazolamide.
    Soricelli A; Postiglione A; Cuocolo A; De Chiara S; Ruocco A; Brunetti A; Salvatore M; Ell PJ
    Stroke; 1995 Sep; 26(9):1572-6. PubMed ID: 7660400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease.
    Touho H; Karasawa J; Ohnishi H
    Stroke; 1996 Feb; 27(2):282-9. PubMed ID: 8571424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the cerebrovascular response to acetazolamide using 99mTc-DTPA-HSA: methodological considerations.
    Inoue Y; Momose T; Machida K; Honda N; Nishikawa J; Sasaki Y
    Radiat Med; 1994; 12(4):189-92. PubMed ID: 7809415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease.
    Ohnishi T; Yano T; Nakano S; Jinnouchi S; Nagamachi S; Flores LI; Nakahara H; Watanabe K
    J Nucl Med; 1997 Sep; 38(9):1463-7. PubMed ID: 9293809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion computed tomography evaluation of cerebral hemodynamic impairment in patients with unilateral chronic steno-occlusive disease: a comparison with the acetazolamide challenge 99mTc-hexamethylpropyleneamine oxime single-photon emission computed tomography.
    Kim E; Sohn CH; Na DG; Kim JE; Chang KH; Kim JH; Jeon SJ
    J Comput Assist Tomogr; 2009; 33(4):546-51. PubMed ID: 19638847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease.
    Webster MW; Makaroun MS; Steed DL; Smith HA; Johnson DW; Yonas H
    J Vasc Surg; 1995 Feb; 21(2):338-44; discussion 344-5. PubMed ID: 7853605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPECT and MRI evaluations of the posterior circulation in moyamoya disease.
    Yamada I; Murata Y; Umehara I; Suzuki S; Matsushima Y
    J Nucl Med; 1996 Oct; 37(10):1613-7. PubMed ID: 8862293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular reactivity to acetazolamide in alert patients with cerebral infarction: usefulness of first-pass radionuclide angiography using 99m Tc-HMPAO in monitoring cerebral haemodynamics.
    Chang CC; Kanno H; Yamamoto I; Kuwana N
    Nucl Med Commun; 2001 Oct; 22(10):1119-22. PubMed ID: 11567185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical features of adult unilateral moyamoya disease: does it have the same clinical characteristics as typical moyamoya disease?
    Ogata T; Yasaka M; Inoue T; Yasumori K; Ibayashi S; Iida M; Okada Y
    Cerebrovasc Dis; 2008; 26(3):244-9. PubMed ID: 18648196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral versus myocardial stress perfusion imaging: role of pharmacological intervention in the diagnostic assessment of flow reserve.
    Machac J; Vallabhajosula S
    J Nucl Med; 1994 Jan; 35(1):41-3. PubMed ID: 8271058
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H; Yamauchi H; Sugimoto K; Takahashi M
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vasodilatory effect of carbon dioxide inhalation and intravenous acetazolamide on brain vasculature using positron emission tomography.
    Gambhir S; Inao S; Tadokoro M; Nishino M; Ito K; Ishigaki T; Kuchiwaki H; Yoshida J
    Neurol Res; 1997 Apr; 19(2):139-44. PubMed ID: 9175142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
    Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
    World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tomographic cerebral blood flow measurements in patients with ischemic cerebrovascular disease and evaluation of the vasodilatory capacity by the acetazolamide test.
    Vorstrup S
    Acta Neurol Scand Suppl; 1988; 114():1-48. PubMed ID: 3259361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative versus quantitative assessment of cerebrovascular reserves.
    Yonas H; Pindzola RR; Meltzer CC; Sasser H
    Neurosurgery; 1998 May; 42(5):1005-10; discussion 1011-2. PubMed ID: 9588544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.